2023/11/09
Keio University School of Medicine
A research team from the Keio University Hospital Memory Center, led by Project Associate Professor Shogyoku Bun of the Department of Neuropsychiatry and Project Professor Daisuke Ito of the Department of Physiology at the Keio University School of Medicine, has announced that the plasma biomarker amyloid-β 42/40 ratio can accurately predict cerebral amyloid-β deposition as measured by amyloid PET scans.
This suggests the potential for high-precision screening of cerebral amyloid-β deposition, a central pathology of Alzheimer's-type dementia, for a wide range of subjects using only a simple blood test.
The results of this research were published in the online edition of the international medical journal Alzheimer's Research & Therapy on September 4, 2023.
Please see below for the full press release.